Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Milo GattiMatteo RinaldiLuciano PotenaElena SalvaterraMaria Cristina MorelliMaddalena GiannellaPierluigi VialeFederico PeaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
and neither CMV eradication nor safety issues was identified.